WHO updates Bacterial Priority Pathogens List to combat antimicrobial resistance

FHS
May 20, 2024
5:23 am

The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritization.

Casgevy: Launch sequence and price analysis of the first marketed CRISPR therapy – Pharmaceutical Technology

In December 2023, Vertex (US) and CRISPR Therapeutics’s (Switzerland and US) Casgevy (exagamglogene autotemcel) was approved in the US for the treatment of sickle cell

August 2, 2024

Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status

New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to chemotherapy before and after surgery for breast cancer

March 20, 2024

The gut microbiota associated with prediabetes and treatment naïve type 2 diabetes patients

The gut-inhabiting bacteria in pre-type 2 diabetes (pre-T2D) patients.

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.